A revolutionary AI-powered diagnostic test for chronic obstructive pulmonary disease (COPD) is set to be introduced in GP ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway ...

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...

The U.S. Food and Drug Administration (FDA) has granted Visby Medical marketing authorization for its Women’s Sexual Health ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting ...

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects ...

Diagnostics' Q4 2024 earnings insights, FDA resubmissions, TB & HPV test pipelines, and international market growth plans.

A new rapid diagnostic test has been developed to identify pregnant women at high risk of transmitting hepatitis B to their babies, particularly in low- and middle-income countries.

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

Proteomics International Laboratories’ OxiDx has secured an Australian patent for a finger-prick test to measure muscle ...